SCHEMBL7549945

SCHEMBL7549945

O[C@H](CCCCl)CCCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.49
TRPV1 Q8NER1 1/20 0.43
GRIK1 P39086 1/20 0.42
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
HDAC4 P56524 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC1 Q13547 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549946 1.00 TRPA1 (0.49) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL5833581 0.90 TRPA1 (0.56) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL2921490 0.86 TRPA1 (0.53) TRPA1TRPV1GRIK1HDAC3MAPK1
Hydrochloric Acid SCHEMBL8852295 0.84 TRPA1 (0.51) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL3115450 0.82 TRPA1 (0.58) TRPA1TRPV1HDAC3MAPK1ADRA1A
SCHEMBL20019603 0.82 TDP1 (0.52) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL7285852 0.82 TDP1 (0.52) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL19682101 0.82 TRPA1 (0.67) TRPA1TRPV1SIGMAR1MAOA
SCHEMBL3652085 0.81 SIGMAR1 (0.49) TRPA1TRPV1GRIK1HDAC3MAPK1
SCHEMBL14402447 0.81 SIGMAR1 (0.49) TRPA1TRPV1GRIK1HDAC3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662958-B1 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS VERTEX PHARMA (US) 2002-12-11 EP disclosed
EP-0584223-B1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMA (US) 1999-08-11 EP disclosed
US-5723459-A IMMUNOSUPPRESSANTS FOR MULTIDRUG RESISTANCE VERTEX PHARMACEUTICALS INCORPORATED (US) 1998-03-03 US disclosed
US-5620971-A Biologically active acylated amino acid derivatives VERTEX PHARMACEUTICALS INCORPORATED (US) 1997-04-15 US disclosed
EP-0662958-A1 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-07-19 EP disclosed
WO-1994007858-A1 1-(2-OXO-ACETYL)-PIPERIDINE-2-CARBOXYLIC ACID DERIVATIVES AS MULTI-DRUG-RESISTENT CANCER CELL SENSITIZERS VERTEX PHARMACEUTICALS INCORPORATED (US) 1994-04-14 WO disclosed
EP-0584223-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1994-03-02 EP disclosed
WO-1992019593-A1 NOVEL IMMUNOSUPPRESSIVE COMPOUNDS VERTEX PHARMACEUTICALS INCORPORATED (US) 1992-11-12 WO disclosed